-transparent.png){kind=logo}
In man, 3 mug per kg per 90 min of linear somatostatin significantly inhibited basal as well as arginine induced insulin and glucagon release. One mug per kg per 90 min of somatostatin significantly inhibited basal insulin release but not basal glucagon release or arginine induced insulin and glucagon release. In the perfused rat pancreas, as little as one ng per ml of perfusate of somatostatin significantly inhibited argine induced insulin but not glucagon release, while 10 ng per ml of somatostatin by more than 50 per cent reduced the effect of arginine on insulin and glucagon release. Thus, linear somatostatin seemed to be a slightly more potent inhibitor of insulin than of glucagon release in man and in the perfused rat pancreas.
S Efendić, and
A Claro, and
R Laft
July 1977,
Acta endocrinologica,
S Efendić, and
A Claro, and
R Laft
January 1982,
Peptides,
S Efendić, and
A Claro, and
R Laft
February 1982,
Endocrinology,
S Efendić, and
A Claro, and
R Laft
December 1977,
FEBS letters,
S Efendić, and
A Claro, and
R Laft
September 1972,
Nature: New biology,
S Efendić, and
A Claro, and
R Laft
September 2002,
Metabolism: clinical and experimental,
S Efendić, and
A Claro, and
R Laft
March 1975,
Acta endocrinologica,
S Efendić, and
A Claro, and
R Laft
January 2009,
Regulatory peptides,
S Efendić, and
A Claro, and
R Laft
September 1996,
Diabetes,
S Efendić, and
A Claro, and
R Laft
November 1979,
Proceedings of the National Academy of Sciences of the United States of America,
